Clinical Trial Detail

NCT ID NCT01028716
Title Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Fred Hutchinson Cancer Research Center
Indications

acute leukemia

acute lymphoblastic leukemia

follicular lymphoma

acute myeloid leukemia

mantle cell lymphoma

marginal zone B-cell lymphoma

myelodysplastic syndrome

multiple myeloma

leukemia

Burkitt lymphoma

Hodgkin's lymphoma

lymphoblastic lymphoma

Therapies

Filgrastim + Mycophenolate mofetil + Tacrolimus

Cyclophosphamide + Fludarabine

Age Groups: child senior adult

Additional content available in CKB BOOST